Etoposide Injection Anti-tumor Medicine

Etoposide Injection Anti-tumor Medicine

This product is a cell cycle specific anti-tumor drug that acts on DNA topoisomerase II, forming a drug enzyme DNA stable reversible complex that hinders DNA repair. The experiment found that this complex can be reversed with the clearance of drugs, repairing damaged DNA and reducing cytotoxicity. Therefore, prolonging the administration time of drugs may enhance their anti-tumor activity.

Product Introduction

Etoposide injection is mainly used for the treatment of small cell lung cancer, malignant lymphoma, malignant germ cell tumor, leukemia, and has certain therapeutic effects on neuroblastoma, rhabdomyosarcoma, ovarian cancer, non-small cell lung cancer, gastric cancer, and esophageal cancer.

This product is a cell cycle specific anti-tumor drug that acts on DNA topoisomerase II, forming a drug enzyme DNA stable reversible complex that hinders DNA repair. The experiment found that this complex can be reversed with the clearance of drugs, repairing damaged DNA and reducing cytotoxicity. Therefore, prolonging the administration time of drugs may enhance their anti-tumor activity.

 

product-800-533

 

Ingredients

 

The main ingredient of this product is etoposide. Its chemical name is 9- [4,6-O - (R) - ethylene - β - D-glucopyranoside] -4 '- demethylated podophyllotoxin.

 

Character

 

This product is a colorless to pale yellow clear liquid.

 

Specifications

 

2ml:40mg.

 

Usage and dosage

 

Intravenous infusion. Dilute the required amount of this product with sodium chloride injection, with a concentration not exceeding 0.25mg per milliliter, and intravenously drip for no less than 30 minutes. Solid tumors: 60-100mg/m [sup] 2 [/sup] per day for 3-5 consecutive days, with repeated medication every 3-4 weeks. Leukemia: 60-100mg/m [sup] 2 [/sup] per day for 5 consecutive days, with repeated administration at regular intervals based on blood count. Common dosage for children: intravenous drip daily at a body surface area of 100-150mg/m2 [sup] 2 [/sup], for 3-4 consecutive days.

 

Attention

 

1. This product should not be administered intravenously, and the speed of intravenous infusion should not be too fast, at least half an hour, otherwise it may cause allergic reactions such as hypotension and laryngeal spasms.

2. Chest, abdominal, and intrathecal injections are not allowed.

3. This product has reproductive toxicity and teratogenicity in animals, and can be excreted through breast milk. Pregnant and lactating women should use it with caution.

During the medication period, regular checks of peripheral blood count and liver and kidney function should be conducted.

5. This product should be used immediately after dilution. If there is precipitation, it is strictly prohibited to use.

 

Storage

 

Protect from light and store in a sealed environment.

 

Hot Tags: etoposide injection anti-tumor medicine, China etoposide injection anti-tumor medicine manufacturers, suppliers, Sodium Chloride and Glucose Infusion, Moxifloxacin Hydrochloride Eye Drops Antifungal Medicine, Cytarabine for Injection Anti tumor Medicine, api, Etoposide Injection Anti tumor Medicine, aminoglycosides

Send Inquiry

whatsapp

Phone

E-mail

Inquiry

Bag